{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:57:58Z","timestamp":1776121078036,"version":"3.50.1"},"reference-count":95,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100015640","name":"Tongji Hospital","doi-asserted-by":"publisher","award":["2024A13"],"award-info":[{"award-number":["2024A13"]}],"id":[{"id":"10.13039\/501100015640","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tumorigenesis and progression are driven by immune dysregulation and escape, thus evaluating immune function is crucial for the identification of diseases or health conditions. Currently, there is a lack of noninvasive biomarkers in the overall management of PCa to assess a patient's immune status and immune response to different treatment regimens. Lymphocyte subsets are directly involved in the surveillance, defense and regulation of the human immune system, and are primarily composed of T cells, B cells, and NK cells. The combined assay of lymphocyte subsets number, phenotype and function is currently a more accepted method of assessing immune function. Quantitative aspects are presented in terms of both absolute counts and relative percentages. Phenotypic molecules reflect host immunity mainly through markers such as HLA-DR, CD25, CD45RO, CD45RA, CCR7, and CD28. Markers, such as IFN-\u03b3, Fas ligand, perforin, granzyme B, TCF-1 (marker for maintaining the stem cell nature, self-renewal, and undifferentiated state), TOX (marker of T cell exhaustion), and immune checkpoint molecules (TIM-3, PD-1, LAG3) can be used to represent the functions of lymphocyte subsets. Nevertheless, existing research conclusions are miscellaneous, and no studies have systematically reviewed the role of lymphocyte subsets in the diagnosis, treatment, and prognosis of PCa. In order to strengthen the comprehensive understanding and grasp of its role by urological surgeons, this review first introduces lymphocyte subsets in detail, and then condenses and summarizes the research progress of lymphocyte subsets in PCa from peripheral blood and tumor infiltration, respectively.<\/jats:p>","DOI":"10.1093\/jleuko\/qiag041","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:46:13Z","timestamp":1773924373000},"source":"Crossref","is-referenced-by-count":0,"title":["Lymphocyte subsets: new hope for noninvasive biomarkers of prostate cancer"],"prefix":"10.1093","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1533-9053","authenticated-orcid":false,"given":"Chunjin","family":"Ke","sequence":"first","affiliation":[{"name":"Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST) , No. 1095, Jiefang Road, Wuhan 430030 ,","place":["China"]},{"name":"Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST) , No. 1095, Jiefang Road, Wuhan 430030 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Hu","sequence":"additional","affiliation":[{"name":"Electrocardiography Room, Liyuan Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST) , No. 39, Lakeside Road, Wuhan 430077 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST) , No. 1095, Jiefang Road, Wuhan 430030 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiquan","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST) , No. 1095, Jiefang Road, Wuhan 430030 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunguang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST) , No. 1095, Jiefang Road, Wuhan 430030 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026041318123971500_qiag041-B1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"2026041318123971500_qiag041-B2","first-page":"27","volume-title":"Chinese guidelines for the diagnosis and treatment of urology and andrology diseases","author":"Huang","year":"2020","edition":"2019 Edition"},{"key":"2026041318123971500_qiag041-B3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.juro.2014.10.084","article-title":"Patterns of repeat prostate biopsy in contemporary clinical practice","volume":"193","author":"Abraham","year":"2015","journal-title":"J Urol"},{"key":"2026041318123971500_qiag041-B4","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1038\/d41586-022-02866-7","article-title":"A better way to biopsy in prostate cancer","volume":"609","author":"Eisenstein","year":"2022","journal-title":"Nature"},{"key":"2026041318123971500_qiag041-B5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.eururo.2022.07.025","article-title":"Prostate cancer detection percentages of repeat biopsy in patients with positive multiparametric magnetic resonance imaging (prostate imaging reporting and data system\/Likert 3-5) and negative initial biopsy. A mini systematic review","volume":"82","author":"Grivas","year":"2022","journal-title":"Eur Urol"},{"key":"2026041318123971500_qiag041-B6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"2026041318123971500_qiag041-B7","doi-asserted-by":"publisher","first-page":"g2559","DOI":"10.1136\/bmj.g2559","article-title":"PSA screening for prostate cancer","volume":"348","author":"Wilt","year":"2014","journal-title":"BMJ"},{"key":"2026041318123971500_qiag041-B8","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1001\/jama.2018.4914","article-title":"Prostate-specific antigen (PSA) screening for prostate cancer: revisiting the evidence","volume":"319","author":"Carter","year":"2018","journal-title":"JAMA"},{"key":"2026041318123971500_qiag041-B9","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"2026041318123971500_qiag041-B10","doi-asserted-by":"publisher","first-page":"9328","DOI":"10.18632\/aging.103208","article-title":"Establishing immune scoring model based on combination of the number, function, and phenotype of lymphocytes","volume":"12","author":"Tang","year":"2020","journal-title":"Aging (Albany, NY)"},{"key":"2026041318123971500_qiag041-B11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3389\/fimmu.2018.00172","article-title":"Establishment of the reference intervals of lymphocyte function in healthy adults based on IFN-gamma secretion assay upon phorbol-12-myristate-13-acetate\/ionomycin stimulation","volume":"9","author":"Hou","year":"2018","journal-title":"Front Immunol"},{"key":"2026041318123971500_qiag041-B12","doi-asserted-by":"publisher","first-page":"12685","DOI":"10.18632\/aging.102595","article-title":"Combination of lymphocyte number and function in evaluating host immunity","volume":"11","author":"Luo","year":"2019","journal-title":"Aging (Albany, NY)"},{"key":"2026041318123971500_qiag041-B13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/cr.2013.155","article-title":"Identification of IFN-gamma-producing innate B cells","volume":"24","author":"Bao","year":"2014","journal-title":"Cell Res"},{"key":"2026041318123971500_qiag041-B14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/82717","article-title":"Reciprocal regulation of polarized cytokine production by effector B and T cells","volume":"1","author":"Harris","year":"2000","journal-title":"Nat Immunol"},{"key":"2026041318123971500_qiag041-B15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026041318123971500_qiag041-B16","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1007\/s00508-011-0096-7","article-title":"Comparative study of frequency of different lymphocytes subpopulation in peripheral blood of patients with prostate cancer and benign prostatic hyperplasia","volume":"123","author":"Sotosek","year":"2011","journal-title":"Wien Klin Wochenschr"},{"key":"2026041318123971500_qiag041-B17","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1158\/1078-0432.CCR-07-2056","article-title":"Enhanced functionality of CD4+CD25(high)FoxP3+ regulatory T cells in the peripheral blood of patients with prostate cancer","volume":"14","author":"Yokokawa","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2026041318123971500_qiag041-B18","doi-asserted-by":"publisher","DOI":"10.27114\/d.cnki.ghnau.2022.001830","article-title":"Distribution characteristics of lymphocyte subsets in peripheral blood of patients with prostate cancer [D]","author":"Zhinan","year":"2022","journal-title":"Henan University"},{"key":"2026041318123971500_qiag041-B19","doi-asserted-by":"publisher","first-page":"109287","DOI":"10.1016\/j.intimp.2022.109287","article-title":"Peripheral blood lymphocyte subsets are associated with the clinical outcomes of prostate cancer patients","volume":"113","author":"Mao","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"2026041318123971500_qiag041-B20","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1186\/s12967-023-04318-w","article-title":"Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte","volume":"21","author":"Yang","year":"2023","journal-title":"J Transl Med"},{"key":"2026041318123971500_qiag041-B21","doi-asserted-by":"publisher","first-page":"387","DOI":"10.11817\/j.issn.1672-7347.2015.04.008","article-title":"Expression of perforin and granzyme-B in peripheral blood lymphocyte in patients with prostate cancer and the clinical significance","volume":"40","author":"He","year":"2015","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"2026041318123971500_qiag041-B22","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1158\/1055-9965.EPI-04-0236","article-title":"Chromosomal instability in peripheral blood lymphocytes and risk of prostate cancer","volume":"14","author":"El-Zein","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026041318123971500_qiag041-B23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10517-016-3256-y","article-title":"Generation of reactive oxygen Species in peripheral blood lymphocytes of patients with prostate cancer","volume":"160","author":"Grekhova","year":"2016","journal-title":"Bull Exp Biol Med"},{"key":"2026041318123971500_qiag041-B24","first-page":"426","article-title":"The effect of intermittent treatment and continuous treatment with goserelin combined with bicalutamide on prostate antigen and immune function in patients with advanced prostate cancer","volume":"26","author":"Zhang","year":"2018","journal-title":"Modern Oncology Medicine"},{"key":"2026041318123971500_qiag041-B25","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3390\/cancers12071716","article-title":"Interleukin-6 and lymphocyte count associated and predicted the progression of frailty syndrome in prostate cancer patients undergoing antiandrogen therapy","volume":"12","author":"Buigues","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026041318123971500_qiag041-B26","doi-asserted-by":"publisher","first-page":"e1496881","DOI":"10.1080\/2162402X.2018.1496881","article-title":"Impact of curative radiotherapy on the immune status of patients with localized prostate cancer","volume":"7","author":"Eckert","year":"2018","journal-title":"Oncoimmunology"},{"key":"2026041318123971500_qiag041-B27","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1007\/s00066-017-1144-7","article-title":"Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients","volume":"193","author":"Sage","year":"2017","journal-title":"Strahlenther Onkol"},{"key":"2026041318123971500_qiag041-B28","first-page":"3159","article-title":"Response of T lymphocyte populations in prostate cancer patients undergoing radiotherapy: influence of neoajuvant total androgen suppression","volume":"25","author":"Johnke","year":"2005","journal-title":"Anticancer Res"},{"key":"2026041318123971500_qiag041-B29","doi-asserted-by":"publisher","first-page":"26422","DOI":"10.18632\/oncotarget.8389","article-title":"Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"2026041318123971500_qiag041-B30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3892\/or.2017.6095","article-title":"Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy","volume":"39","author":"Kubo","year":"2018","journal-title":"Oncol Rep"},{"key":"2026041318123971500_qiag041-B31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s12672-022-00603-0","article-title":"Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy","volume":"13","author":"Neuberger","year":"2022","journal-title":"Discov Oncol"},{"key":"2026041318123971500_qiag041-B32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/MOU.0b013e3282f9b3b7","article-title":"Inflammation, infection, and prostate cancer","volume":"18","author":"Klein","year":"2008","journal-title":"Curr Opin Urol"},{"key":"2026041318123971500_qiag041-B33","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/pros.21027","article-title":"Inflammation in benign prostatic hyperplasia: a 282 patients\u2019 immunohistochemical analysis","volume":"69","author":"Robert","year":"2009","journal-title":"Prostate"},{"key":"2026041318123971500_qiag041-B34","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"key":"2026041318123971500_qiag041-B35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/cmi.2009.117","article-title":"Enhancement of antitumor immunity by low-dose total body irradiation is associated with selectively decreasing the proportion and number of T regulatory cells","volume":"7","author":"Liu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"2026041318123971500_qiag041-B36","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12885-024-11929-z","article-title":"A nomogram based on peripheral lymphocyte for predicting 8-year survival in patients with prostate cancer: a single-center study using LASSO-Cox regression","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"key":"2026041318123971500_qiag041-B37","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00345-019-02752-4","article-title":"Evaluation of neutrophil-to-lymphocyte ratio as a prognostic indicator in a Singapore cohort of patients with clinically localized prostate cancer treated with prostatectomy","volume":"38","author":"Lu","year":"2020","journal-title":"World J Urol"},{"key":"2026041318123971500_qiag041-B38","doi-asserted-by":"publisher","first-page":"907625","DOI":"10.3389\/fonc.2022.907625","article-title":"The values of systemic immune-inflammation index and neutrophil-lymphocyte ratio in predicting biochemical recurrence in patients with localized prostate cancer after radical prostatectomy","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"2026041318123971500_qiag041-B39","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/cam4.1984","article-title":"The preoperative neutrophil-to-lymphocyte ratio is not a marker of prostate cancer characteristics but is an independent predictor of biochemical recurrence in patients receiving radical prostatectomy","volume":"8","author":"Cao","year":"2019","journal-title":"Cancer Med"},{"key":"2026041318123971500_qiag041-B40","first-page":"2126","article-title":"Neutrophil to lymphocyte ratio and prostate specific antigen in predication of castrate-resistant prostate cancer in patients with prostate cancer","volume":"18","author":"Song","year":"2020","journal-title":"Cancer Prog."},{"key":"2026041318123971500_qiag041-B41","doi-asserted-by":"publisher","DOI":"10.27674\/d.cnki.gcyku.2022.000656","article-title":"Analysis of predictors of castration resistance in prostate cancer after endocrine therapy [D]","author":"Peng","year":"2022","journal-title":"Chongqing Medical University"},{"key":"2026041318123971500_qiag041-B42","doi-asserted-by":"publisher","DOI":"10.27026\/d.cnki.ggszc.2023.000514","article-title":"Analysis of factors influencing the progression of prostate cancer to CRPC after endocrine therapy and establishment of a nomogram model [D]","author":"Guo","year":"2023","journal-title":"Gansu University of Traditional Chinese Medicine"},{"key":"2026041318123971500_qiag041-B43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.23736\/S2724-6051.21.04186-2","article-title":"Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide","volume":"73","author":"Pisano","year":"2021","journal-title":"Minerva Urol Nephrol"},{"key":"2026041318123971500_qiag041-B44","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1186\/s12885-020-07410-2","article-title":"A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo Abiraterone acetate or enzalutamide treatment","volume":"20","author":"Kawahara","year":"2020","journal-title":"BMC Cancer"},{"key":"2026041318123971500_qiag041-B45","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41391-020-0209-3","article-title":"Revealing the prognostic landscape of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: a meta-analysis","volume":"23","author":"Guan","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2026041318123971500_qiag041-B46","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/pros.24597","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapy","volume":"83","author":"Stangl-Kremser","year":"2023","journal-title":"Prostate"},{"key":"2026041318123971500_qiag041-B47","doi-asserted-by":"publisher","first-page":"e35843","DOI":"10.1097\/MD.0000000000035843","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value in metastatic castration-resistant prostate cancer patients who underwent 177Lu-PSMA-617","volume":"102","author":"Sahin","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"2026041318123971500_qiag041-B48","doi-asserted-by":"publisher","first-page":"201.e9","DOI":"10.1016\/j.urolonc.2015.02.002","article-title":"Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy","volume":"33","author":"Langsenlehner","year":"2015","journal-title":"Urol Oncol"},{"key":"2026041318123971500_qiag041-B49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12885-016-2363-5","article-title":"Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Cancer"},{"key":"2026041318123971500_qiag041-B50","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ijsu.2018.11.020","article-title":"Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: a meta-analysis of results from multivariate analysis","volume":"60","author":"Guo","year":"2018","journal-title":"Int J Surg"},{"key":"2026041318123971500_qiag041-B51","doi-asserted-by":"publisher","first-page":"15579883241234747","DOI":"10.1177\/15579883241234747","article-title":"Prognostic value of lymphocyte-to-monocyte ratio (LMR) in patients with prostate cancer: a systematic review and meta-analysis","volume":"18","author":"Xiang","year":"2024","journal-title":"Am J Mens Health"},{"key":"2026041318123971500_qiag041-B52","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2026041318123971500_qiag041-B53","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.4049\/jimmunol.0902583","article-title":"Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance","volume":"185","author":"Augier","year":"2010","journal-title":"J Immunol"},{"key":"2026041318123971500_qiag041-B54","doi-asserted-by":"publisher","first-page":"e474","DOI":"10.1016\/j.clgc.2023.05.015","article-title":"Pretreatment lymphocyte to C-reactive protein ratio: an independent predictor of overall survival in metastatic hormone-naive prostate cancer patients","volume":"21","author":"Sasaki","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"2026041318123971500_qiag041-B55","doi-asserted-by":"publisher","DOI":"10.27202\/d.cnki.gkmyc.2020.000642","article-title":"Retrospective analysis of the role of CRP and IL-6 in the diagnosis and prognosis of prostate cancer [D]","author":"Luo","year":"2020","journal-title":"Kunming Medical University"},{"key":"2026041318123971500_qiag041-B56","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","article-title":"Inflammation and cancer: advances and new agents","volume":"12","author":"Crusz","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"key":"2026041318123971500_qiag041-B57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.yexmp.2008.11.010","article-title":"Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma","volume":"86","author":"Hussein","year":"2009","journal-title":"Exp Mol Pathol"},{"key":"2026041318123971500_qiag041-B58","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","article-title":"Paradoxical roles of the immune system during cancer development","volume":"6","author":"de Visser","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2026041318123971500_qiag041-B59","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","article-title":"Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial","volume":"23","author":"Gurel","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026041318123971500_qiag041-B60","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2011.03.055","article-title":"The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation","volume":"60","author":"De Nunzio","year":"2011","journal-title":"Eur Urol"},{"key":"2026041318123971500_qiag041-B61","doi-asserted-by":"publisher","DOI":"10.27157\/d.cnki.ghzku.2019.001876","article-title":"Analysis of tumor infiltrating T cell phenotype and expression of PD1 and PD-L1 in prostate cancer [D]","author":"Wei","year":"2019","journal-title":"Huazhong University of Science and Technology"},{"key":"2026041318123971500_qiag041-B62","first-page":"120","article-title":"Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer","volume":"1","author":"Gannot","year":"2011","journal-title":"Am J Cancer Res"},{"key":"2026041318123971500_qiag041-B63","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2147\/OTT.S161302","article-title":"Vascular endothelial growth factor suppresses dendritic cells function of human prostate cancer","volume":"11","author":"Bai","year":"2018","journal-title":"Onco Targets Ther"},{"key":"2026041318123971500_qiag041-B64","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.molonc.2014.07.013","article-title":"Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11\u2013&gt;miRNA-541\u2013&gt;androgen receptor (AR)\u2013&gt;MMP9 signaling","volume":"9","author":"Hu","year":"2015","journal-title":"Mol Oncol"},{"key":"2026041318123971500_qiag041-B65","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41556-020-00616-3","article-title":"Prostate cancer hijacks the microenvironment","volume":"23","author":"Thienger","year":"2021","journal-title":"Nat Cell Biol"},{"key":"2026041318123971500_qiag041-B66","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.4049\/jimmunol.177.10.7398","article-title":"CD4+ CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients","volume":"177","author":"Miller","year":"2006","journal-title":"J Immunol"},{"key":"2026041318123971500_qiag041-B67","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1001\/jama.2018.11716","article-title":"Prostate cancer-specific mortality across Gleason scores in black vs nonblack men","volume":"320","author":"Mahal","year":"2018","journal-title":"JAMA"},{"key":"2026041318123971500_qiag041-B68","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1479-5876-12-30","article-title":"Tumor infiltrating B-cells are increased in prostate cancer tissue","volume":"12","author":"Woo","year":"2014","journal-title":"J Transl Med"},{"key":"2026041318123971500_qiag041-B69","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1101\/gad.220202.113","article-title":"An IKKalpha-E2F1-BMI1 cascade activated by infiltrating B cells controls prostate regeneration and tumor recurrence","volume":"27","author":"Ammirante","year":"2013","journal-title":"Genes Dev"},{"key":"2026041318123971500_qiag041-B70","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"key":"2026041318123971500_qiag041-B71","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1007\/s00262-010-0897-y","article-title":"Identification and characterization of a tumor infiltrating CD56(+)\/CD16 (\u2212) NK cell subset with specificity for pancreatic and prostate cancer cell lines","volume":"59","author":"Frankel","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"2026041318123971500_qiag041-B72","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1172\/JCI69369","article-title":"Perturbation of NK cell peripheral homeostasis accelerates prostate carcinoma metastasis","volume":"123","author":"Liu","year":"2013","journal-title":"J Clin Invest"},{"key":"2026041318123971500_qiag041-B73","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.4049\/jimmunol.175.4.2741","article-title":"Activation of thymic regeneration in mice and humans following androgen blockade","volume":"175","author":"Sutherland","year":"2005","journal-title":"J Immunol"},{"key":"2026041318123971500_qiag041-B74","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ccr.2005.01.027","article-title":"Androgen ablation mitigates tolerance to a prostate\/prostate cancer-restricted antigen","volume":"7","author":"Drake","year":"2005","journal-title":"Cancer Cell"},{"key":"2026041318123971500_qiag041-B75","doi-asserted-by":"publisher","first-page":"14565","DOI":"10.1073\/pnas.251140998","article-title":"T cell infiltration of the prostate induced by androgen withdrawal in patients with prostate cancer","volume":"98","author":"Mercader","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041318123971500_qiag041-B76","doi-asserted-by":"publisher","first-page":"9335","DOI":"10.18632\/oncotarget.2429","article-title":"Androgen deprivation therapy sensitizes prostate cancer cells to T-cell killing through androgen receptor dependent modulation of the apoptotic pathway","volume":"5","author":"Ardiani","year":"2014","journal-title":"Oncotarget"},{"key":"2026041318123971500_qiag041-B77","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2009.11.023","article-title":"Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer","volume":"292","author":"Chiu","year":"2010","journal-title":"Cancer Lett"},{"key":"2026041318123971500_qiag041-B78","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41419-020-02973-1","article-title":"Immune signature driven by ADT-induced immune microenvironment remodeling in prostate cancer is correlated with recurrence-free survival and immune infiltration","volume":"11","author":"Long","year":"2020","journal-title":"Cell Death Dis"},{"key":"2026041318123971500_qiag041-B79","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.immuni.2022.05.012","article-title":"Androgen receptor-mediated CD8(+) T cell stemness programs drive sex differences in antitumor immunity","volume":"55","author":"Yang","year":"2022","journal-title":"Immunity"},{"key":"2026041318123971500_qiag041-B80","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41586-022-04522-6","article-title":"Androgen receptor activity in T cells limits checkpoint blockade efficacy","volume":"606","author":"Guan","year":"2022","journal-title":"Nature"},{"key":"2026041318123971500_qiag041-B81","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1158\/1078-0432.CCR-16-1780","article-title":"Sequencing of sipuleucel-T and androgen deprivation therapy in men with hormone-sensitive biochemically recurrent prostate cancer: a phase II randomized trial","volume":"23","author":"Antonarakis","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2026041318123971500_qiag041-B82","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00262-011-1193-1","article-title":"Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer","volume":"61","author":"McNeel","year":"2012","journal-title":"Cancer Immunol Immunother"},{"key":"2026041318123971500_qiag041-B83","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1200\/JCO.2009.25.0597","article-title":"Overall survival analysis of a phase II randomized controlled trial of a poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer","volume":"28","author":"Kantoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"2026041318123971500_qiag041-B84","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.7150\/thno.73152","article-title":"Docetaxel remodels prostate cancer immune microenvironment and enhances checkpoint inhibitor-based immunotherapy","volume":"12","author":"Ma","year":"2022","journal-title":"Theranostics"},{"key":"2026041318123971500_qiag041-B85","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/sj.bjc.6601943","article-title":"The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer","volume":"91","author":"McArdle","year":"2004","journal-title":"Br J Cancer"},{"key":"2026041318123971500_qiag041-B86","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.14670\/HH-28.1621","article-title":"Dendritic and lymphocytic cell infiltration in prostate carcinoma","volume":"28","author":"Liu","year":"2013","journal-title":"Histol Histopathol"},{"key":"2026041318123971500_qiag041-B87","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1002\/pros.22862","article-title":"Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer","volume":"74","author":"Ness","year":"2014","journal-title":"Prostate"},{"key":"2026041318123971500_qiag041-B88","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/pros.24064","article-title":"Inflammatory infiltration is associated with AR expression and poor prognosis in hormone naive prostate cancer","volume":"80","author":"McAllister","year":"2020","journal-title":"Prostate"},{"key":"2026041318123971500_qiag041-B89","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1016\/j.ejca.2009.02.015","article-title":"Prostate cancer lesions are surrounded by FOXP3+, PD-1+ and B7-H1+ lymphocyte clusters","volume":"45","author":"Ebelt","year":"2009","journal-title":"Eur J Cancer"},{"key":"2026041318123971500_qiag041-B90","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/modpathol.2012.164","article-title":"CD4 helper T cells, CD8 cytotoxic T cells, and FOXP3(+) regulatory T cells with respect to lethal prostate cancer","volume":"26","author":"Davidsson","year":"2013","journal-title":"Mod Pathol"},{"key":"2026041318123971500_qiag041-B91","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00262-014-1591-2","article-title":"Correlation between frequencies of blood monocytic myeloid-derived suppressor cells, regulatory T cells and negative prognostic markers in patients with castration-resistant metastatic prostate cancer","volume":"63","author":"Idorn","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"2026041318123971500_qiag041-B92","doi-asserted-by":"publisher","first-page":"3847","DOI":"10.1158\/1078-0432.CCR-16-2047","article-title":"The interplay between neutrophils and CD8(+) T cells improves survival in human colorectal cancer","volume":"23","author":"Governa","year":"2017","journal-title":"Clin Cancer Res"},{"key":"2026041318123971500_qiag041-B93","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pros.24068","article-title":"High intratumoral CD8(+) T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy","volume":"81","author":"Yang","year":"2021","journal-title":"Prostate"},{"key":"2026041318123971500_qiag041-B94","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00262-014-1524-0","article-title":"A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates","volume":"63","author":"Jochems","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"2026041318123971500_qiag041-B95","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/2326-6066.CIR-14-0227","article-title":"Preexisting levels of CD4 T cells expressing PD-1 are related to overall survival in prostate cancer patients treated with ipilimumab","volume":"3","author":"Kwek","year":"2015","journal-title":"Cancer Immunol Res"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jleukbio\/advance-article-pdf\/doi\/10.1093\/jleuko\/qiag041\/67423315\/qiag041.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/118\/4\/qiag041\/67423315\/qiag041.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/118\/4\/qiag041\/67423315\/qiag041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T22:12:47Z","timestamp":1776118367000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/doi\/10.1093\/jleuko\/qiag041\/8529716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4,2]]}},"URL":"https:\/\/doi.org\/10.1093\/jleuko\/qiag041","relation":{},"ISSN":["1938-3673"],"issn-type":[{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,20]]},"article-number":"qiag041"}}